5567045140 · Annan naturvetenskaplig och teknisk forskning och utveckling · STOCKHOLM
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Net sales for 2024 came to 10.8 MSEK, down 88.9 % on the previous period. The operating margin declined from -102.6 % to -123.7 % in 2024. InDex Pharmaceuticals AB held cash corresponding to roughly 55.2 % of total assets at the period end. In 2024, net sales corresponded to roughly 5.4 MSEK per employee (2 employees).
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
10.8 MSEK
▼ −89%Net result
-2.2 MSEK
▲ +97%Employees
2
▼ −60%Per the signatures in the annual report for the fiscal year ending 2024-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
arkivnord